News

Improve Best Practices Adoption With Acceleration Strategies

By Troy Polan, Chief Technology Officer, ExceleraRx Corp

Adopting best practices is key to improving quality of care, but once those ideal strategies are identified, it can take an agonizingly long time to actually get an organization to start using them consistently. Some healthcare organizations are finding ways to cut down that long introduction period, which can mean achieving improvements years sooner. 

Patient-Centered Multidisciplinary Care Key to Value-based Care

One of many benefits of attending the 2019 Pharmacy Quality Alliance (PQA) Annual Meeting is the actionable insights gleaned from conversations and sessions regarding every corner of the industry. This year, informed discussions surrounding the development of measures to improve medication services and how pharmacists can play a larger role in the multidisciplinary care team were a focus of the event.

Joining Forces in Specialty Pharmacy

Lorrie A. Carr, MBA, the CEO of ExcleraRX, talks with SPC Editorial Director David Bronstein about specialty pharmacies in health systems joining together to gain the scale needed to compete in the market.

Health Systems’ Role in Specialty Pharmacy Moves Into Focus at Asembia

Becky Rand, Vice President of Manufacturer Relations, ExceleraRx Corp.

As the largest conference in the United States focused solely on specialty pharmacy, the Asembia Specialty Pharmacy Summit presents an unparalleled and unique opportunity to analyze the big picture of the industry and its key players. 

How hospitals can better align the pharmacy to achieve its strategic goals

As hospitals face the dual pressure of improving patient satisfaction and lowering costs, they are increasingly turning to their pharmacies for help on both fronts. At a May 3 session at the Becker’s Hospital Review 2nd Health IT + Clinical Leadership + Pharmacy 2019 conference, a panel of experts discussed the evolving role of pharmacists at their organizations.

2019 Asembia Specialty Pharmacy Summit: 3 Key Takeaways

Each year, the Asembia Specialty Pharmacy Summit welcomes thousands of key stakeholders from specialty pharmacy, including drug manufacturers, industry analysts, health systems representatives, health plans, and pharmacies, in order to discuss key issues affecting the industry. This year, at the 15th annual meeting in Las Vegas, was no different.

AMCP: Industry Shifts to Benefit Complex Patients

By Becky Rand, VP Manufacturer Relations, ExceleraRx Corp

As the number of patients being treated for one or more chronic diseases continues to grow, providers are taking new approaches to more effectively manage this complex population.

URAC-Accredited Specialty Pharmacies Demonstrate Improved Measures for the 2018 Reporting Year

A total of 131 URAC-accredited specialty pharmacy organizations submitted their 2017 measurement year data to URAC for the 2018 reporting year, which is a significant increase in the number of reporting organizations from the prior year.

Health-System Specialty Pharmacies Shine at IDN Meeting

Health-system specialty pharmacies are presenting their best selves at CBI’s Partnering with IDNs (Integrated Delivery Networks) BioPharma Strategy Summit West. Several organizations have made the case that they are the ideal specialty drug providers because of the unique advantages of having access to clinical staff and electronic health records (EHRs).

Insider Advice on Building a Successful IDN-Based Specialty Pharmacy

The growing trend toward specialty pharmacy at the point of care is unstoppable. For many integrated delivery networks (IDNs), including large health systems and academic medical centers, the clinical and financial benefits of establishing an in-house specialty pharmacy are clear.